Spot Trading’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-337
Closed -$32.7K 3095
2017
Q2
$34K Buy
+337
New +$36.3K ﹤0.01% 2917
2016
Q2
Sell
-75
Closed -$9.05K 3344
2016
Q1
$8K Buy
+75
New +$7.79K ﹤0.01% 3172
2015
Q4
Sell
-3,980
Closed -$456K 3648
2015
Q3
$397K Sell
3,980
-336
-8% -$36.5K ﹤0.01% 2212
2015
Q2
$492K Buy
4,316
+4,313
+143,767% +$523K ﹤0.01% 2132
2015
Q1
$0 Sell
3
-11,926
-100% -$1.27M ﹤0.01% 3942
2014
Q4
$1.44M Buy
11,929
+8,662
+265% +$1.14M 0.01% 1642
2014
Q3
$478K Buy
3,267
+2,138
+189% +$330K ﹤0.01% 2592
2014
Q2
$189K Sell
1,129
-8,882
-89% -$1.58M ﹤0.01% 3372
2014
Q1
$1.99M Buy
+10,011
New +$1.89M 0.01% 1509

Other funds holding CLB

Spot Trading's CLB Position: Q3 2017 in Review

Spot Trading sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 337 shares — an estimated $32.7K sold.

Spot Trading first reported a position in CLB in Q1 2014 and held it in 9 quarters. The position peaked at $1.99M in Q1 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Spot Trading reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 337 Core Laboratories shares in Q3 2017, an estimated $32.7K.
  • Spot Trading first reported a position in Core Laboratories in Q1 2014 and held it in 9 quarters.
  • Spot Trading's Core Laboratories position peaked at $1.99M in Q1 2014.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.